SJP-004

N/A

Report date: 2023/03/04 19:33:08
NME

Base Information

Drug NameSJP-004
Drug Alias NameSJP-004
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHepatitis BHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesSamjin
China Registration ClassN/A

Develop Information

Active CompaniesSamjin
Inactive CompaniesN/A
Active IndicationsHepatitis BHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A